Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers
Merus B.V.
Merus B.V.
University of Chicago
OHSU Knight Cancer Institute
SCRI Development Innovations, LLC
Universitätsklinikum Hamburg-Eppendorf
Boehringer Ingelheim
Boehringer Ingelheim